SCHEMBL17886998

SCHEMBL17886998

Brc1c(-c2ccccc2)c(-c2ccccc2)n(-c2ccccc2)c1-c1ccccc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.40
▸ SMN1; SMN2 Q16637 3/20 0.40
▸ KDM4E B2RXH2 3/20 0.40
▸ HPGD P15428 2/20 0.40
▸ LMNA P02545 2/20 0.40
▸ KMT2A Q03164 6/20 0.38
▸ IL1R1 P14778 1/20 0.38
▸ MEN1 O00255 5/20 0.37
▸ L3MBTL1 Q9Y468 2/20 0.37
▸ MAPT P10636 2/20 0.37
▸ HTT P42858 2/20 0.37
▸ RECQL P46063 2/20 0.36
▸ POLB P06746 1/20 0.36
▸ ATM Q13315 1/20 0.35
▸ GAA P10253 2/20 0.35
▸ AVPR1A P37288 1/20 0.35
▸ DCTPP1 Q9H773 1/20 0.35
▸ MAPK1 P28482 1/20 0.34
▸ GSK3A P49840 2/20 0.34
▸ GSK3B P49841 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17911727 0.87 ALDH1A1 (0.44) ALDH1A1SMN1; SMN2KDM4EHPGDLMNA
SCHEMBL11910210 0.82 ALDH1A1 (0.40) ALDH1A1SMN1; SMN2KDM4EHPGDLMNA
SCHEMBL12103572 0.78 ALDH1A1 (0.38) ALDH1A1SMN1; SMN2KDM4EHPGDLMNA
SCHEMBL18701263 0.78 KMT2A (0.46) ALDH1A1SMN1; SMN2KDM4EHPGDLMNA
SCHEMBL31070140 0.77 DCTPP1 (0.54) SMN1; SMN2LMNAKMT2AMEN1HTT
SCHEMBL23665412 0.76 ALDH1A1 (0.46) ALDH1A1SMN1; SMN2KDM4EHPGDKMT2A
SCHEMBL5012020 0.76 ALDH1A1 (0.46) ALDH1A1SMN1; SMN2KDM4EHPGDLMNA
SCHEMBL15085213 0.75 IL1R1 (0.57) ALDH1A1SMN1; SMN2KDM4EHPGDLMNA
SCHEMBL5012008 0.73 ALDH1A1 (0.47) ALDH1A1SMN1; SMN2KDM4EHPGDLMNA
SCHEMBL18701272 0.73 SMN1; SMN2 (0.43) ALDH1A1SMN1; SMN2KDM4EHPGDLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10294203-B2 Organic compound and electronic device comprising an organic layer comprising the organic compound DOW GLOBAL TECHNOLOGIES LLC (US) 2019-05-21 — — US disclosed
US-20170334849-A1 ORGANIC COMPOUND AND ELECTRONIC DEVICE COMPRISING AN ORGANIC LAYER COMPRISING THE ORGANIC COMPOUND DOW GLOBAL TECHNOLOGIES LLC (US) 2017-11-23 — — US disclosed
US-20170334849-A1 ORGANIC COMPOUND AND ELECTRONIC DEVICE COMPRISING AN ORGANIC LAYER COMPRISING THE ORGANIC COMPOUND DOW GLOBAL TECHNOLOGIES LLC (US) 2017-11-23 — — US disclosed
WO-2016101721-A1 ORGANIC COMPOUND AND ELECTRONIC DEVICE COMPRISING ORGANIC LAYER COMPRISING THEREOF DOW GLOBAL TECHNOLOGIES LLC (US) 2016-06-30 — — WO disclosed
WO-2016101250-A1 ORGANIC COMPOUND AND ELECTRONIC DEVICE COMPRISING AN ORGANIC LAYER COMPRISING THE ORGANIC COMPOUND DOW GLOBAL TECHNOLOGIES LLC (US) 2016-06-30 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170334849-A1 ORGANIC COMPOUND AND ELECTRONIC DEVICE COMPRISING AN ORGANIC LAYER COMPRISING THE ORGANIC COMPOUND OR10J3, OCIAD2, OCIAD1 ALDH1A1 1041/4885SMN1; SMN2 3943/4885KDM4E 1979/4885
US-10294203-B2 Organic compound and electronic device comprising an organic layer comprising the organic compound OR10J3, OCIAD2, OCIAD1 ALDH1A1 1041/4885SMN1; SMN2 3943/4885KDM4E 1979/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback